Marksans Pharma Share Price Target 2025 2026 2027 2028

Marksans Pharma Ltd, a leading player in the pharmaceutical sector, has been making notable strides in its stock market performance. Recently listed on the stock exchanges, the company’s share price has shown a significant upward trend, attributed to its strong reputation and goodwill earned through years of reliable service and customer trust.

Current Share Price Insights

• Current Trading Price: The shares of Marksans Pharma Ltd are currently trading at ₹140 INR.
• Price Fluctuations: The share price has decreased by 0.25% from its previous closing price.
• Price Range: The trading range for the shares is between ₹138.50 INR and ₹144 INR.
• Recent Performance: Over the past five days, the share price has increased by 0.11%.
• Yearly Performance: Compared to the last year, the share price has dropped by 12.10%.

Future Share Price Predictions

• 2024 Target: ₹154.1 INR
• 2025 Target: ₹253.54 INR
• 2026 Target: ₹257.17 INR
• 2027 Target: ₹279.79 INR
• 2028 Target: ₹303.56 INR
• 2029 Target: ₹328.5 INR
• 2030 Target: ₹354.72 INR

These predictions are based on the company’s historical and current performance on the stock exchange.

Growth Metrics

• Sales Growth: The company has seen a 9.8% increase in sales over the past year, 15.78% over the last three years, and 24.98% over the last five years.
• 52-Week Range: The highest share price recorded in the last 52 weeks is ₹179.3 INR, while the lowest is ₹68.5 INR.
• Pharma Sector Rank: Marksans Pharma Ltd is ranked 74th in the pharmaceutical sector.
• Future Earnings Growth: Forecasts suggest the company’s earnings will grow by 20.06% annually.
• Net Profit Increase: The net profit has increased by 31.27% compared to the previous year’s profit.

Marksans Pharma Share Price Target 2024-2030

2024

Month	Target Price
January	154.1
February	158.87
March	154.1
April	151.69
May	154.28
June	179.27
July	179.3
August	179.29
September	179.31
October	219.81
November	219.8
December	219.82

2025

Month	Target Price
January	235.54
February	240.33
March	235.55
April	233.16
May	233.17
June	233.14
July	233.18
August	233.6
September	233.21
October	233.18
November	233.16
December	233.15

2026

Month	Target Price
January	257.17
February	261.92
March	257.16
April	254.72
May	254.76
June	254.8
July	254.77
August	254.76
September	254.73
October	254.74
November	245.77
December	254.75

2027

Month	Target Price
January	279.79
February	284.53
March	279.73
April	277.31
May	277.34
June	277.36
July	277.37
August	277.39
September	277.41
October	277.42
November	277.43
December	277.4

2028

Month	Target Price
January	303.56
February	308.3
March	303.51
April	301.12
May	301.16
June	301.21
July	301.19
August	301.22
September	301.24
October	301.21
November	301.22
December	301.21

2029

Month	Target Price
January	328.5
February	333.31
March	328.53
April	326.15
May	326.13
June	326.15
July	326.18
August	326.17
September	326.21
October	326.24
November	326.21
December	326.21

2030

Month	Target Price
January	354.72
February	359.53
March	354.75
April	352.38
May	352.35
June	352.34
July	352.3
August	352.34
September	352.37
October	352.34
November	352.36
December	352.35

Marksans Pharma Ltd Financials

• Market Capitalization Value: ₹3527.88 crores
• Total Share Capital: ₹45.32 crores
• Long Term Investments: ₹265.75 crores
• Short Term Investments: ₹0.54 crores
• Total Inventories: ₹130.95 crores
• Long Term Provisions: ₹3.18 crores
• Short Term Provisions: ₹1.33 crores
• Total Assets: ₹1344.86 crores
• Total Contingent Liabilities: ₹9.31 crores
• Total Revenue: ₹715.69 crores
• Total Expenses: ₹583.65 crores
• Finance Costs: ₹3.61 crores
• Equity Dividend Rate: 50%
• Asset Turnover Ratio: 0.57%
• Earnings Yield Ratio: 0.03%
• Dividend Payout Ratio: 9.88%
• Inventory Turnover Ratio: 2.89%
• EPS: 2.35
• ROCE: 16.11%
• ROE: 19.31%
• PE Ratio: 33.13%
• PB Ratio: 1.95%
• Dividend Yield Ratio: 0.32%
• Return on Assets: 7.64%
• Book Value: ₹26.35 crores

Marksans Pharma Ltd Shareholding Pattern

Shareholders	Share Percentage
Promoters	43.85%
FII	15.11%
DII	1.47%
Public	39.58%

Marksans Pharma Ltd Competitors

• Sun Pharmaceuticals India Ltd
• Aarti Drugs Ltd
• Cipla Ltd
• Natco Pharma
• Suven Pharma

Points to Consider Before Investing in Marksans Pharma Ltd

• Check the company’s performance on stock exchanges for the current as well as past years and make a rough comparison.
• Consider all the risk factors before making any investment and keep them noted in your mind even after the investment.
• Check the tax implications on the shares and observe the trends of tax percentages as it fluctuates in every financial year.
• Do not opt for any loans for investment purposes; invest a favorable amount only according to your capabilities.
• Keep on checking the share prices as they can fluctuate at any point in time.

Conclusion

Marksans Pharma Ltd continues to show robust performance in the stock market, with a promising outlook for future growth. Investors can expect steady growth in share prices, supported by the company’s strong sales and earnings forecasts.

Also read about DDJAY Plots in Sohna (Deen Dayal Jan Awas Yojna

FAQs: